Seeing Is Believing

Currently out of the existing stock ratings of Raghuram Selvaraju, 1412 are a BUY (94.32%), 80 are a HOLD (5.34%), 5 are a SELL (0.33%).
Analyst Raghuram Selvaraju, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 39.44% that have a potential upside of 54.73% achieved within 221 days.
Raghuram Selvaraju’s has documented 2,743 price targets and ratings displayed on 149 stocks. The coverage is on Healthcare, Basic Materials, Consumer Defensive, Technology, Utilities, Consumer Cyclical, Communication Services sectors.
Most recent stock forecast was given on AQST, Aquestive Therapeutics at 24-Aug-2026.
Analyst best performing recommendations are on CGTX (COGNITION THERAPEUTICS).
The best stock recommendation documented was for CGTX (COGNITION THERAPEUTICS) at 6/26/2025. The price target of $3 was fulfilled within 60 days with a profit of $2.68 (837.5%) receiving and performance score of 139.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-Oct-2022
$12
$-1.97 (-14.10%)
$800
Buy Since 25-Oct-2023
$20
$5.52 (38.12%)
Hold Since 19-Jul-2023
$25
$10.52 (72.65%)
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?